← Back to Search

Behavioural Intervention

TMS for Cerebral Palsy

N/A
Recruiting
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months

Summary

This trial will help researchers learn if it's possible to do a bigger study comparing the effects of CIMT and TMS versus CIMT and fake TMS in children with CP, as well as if there are any benefits to adding TMS.

Eligible Conditions
  • Cerebral Palsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Effectiveness of the transcrainial magnetic stimulation blinding process on patients and therapist
Estimation of intervention costs
Evaluation of Participant recruitment
+3 more
Secondary study objectives
Assessment of mobility using Small Kids-AHA
Assessment of mobility using the Canadian Occupational Performance Measure (COPM)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transcranial magnetic stimulation with constraint induced movement therapyExperimental Treatment1 Intervention
CIMT/TMS: Five participants will receive a one-hour weekly occupational therapy session of CIMT with 2-hours of daily home program for a total of 6 weeks; immediately prior to initiation of each CIMT session, participants will receive 20 minutes of TMS 1HZ.
Group II: constraint induced movement therapy Sham transcrianial magnetic stimulationPlacebo Group1 Intervention
(CIMT/sham TMS): Five participants will receive a one-hour weekly session of CIMT with 2-hours daily of home program for a total of 6 weeks; immediately prior to initiation of each CIMT session, participants will receive 20 minutes of sham TMS 1HZ.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial magnetic stimulation
2015
Completed Phase 4
~590

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
620 Previous Clinical Trials
206,771 Total Patients Enrolled
2 Trials studying Cerebral Palsy
110 Patients Enrolled for Cerebral Palsy

Media Library

Constraint Induced Movement Therapy (CIMT) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04902521 — N/A
Cerebral Palsy Research Study Groups: Transcranial magnetic stimulation with constraint induced movement therapy, constraint induced movement therapy Sham transcrianial magnetic stimulation
Cerebral Palsy Clinical Trial 2023: Constraint Induced Movement Therapy (CIMT) Highlights & Side Effects. Trial Name: NCT04902521 — N/A
Constraint Induced Movement Therapy (CIMT) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04902521 — N/A
~3 spots leftby Nov 2025